Success Guarantee Packages

We want to partner with you in achieving our shared goal of pregnancy success.

Because we believe in our outstanding clinical expertise and pregnancy success statistics, we offer risk sharing, or Success Guarantee, financial plans. We hope that these plans offer you another financial option, while emphasizing our commitment to shared success in achieving your goal: a baby. For more information, contact SDFC’s financial department.

The Principle of Mutual Commitment

Our IVF guarantee programs are based on the principle of mutual commitment. If you do not achieve a live birth after completing a Success Guarantee cycle, you will be reimbursed up to 100 percent of the cycle fee.

Frozen Embryo Transfer Fees

Success Guarantee plans include cycle fees to transfer all frozen embryos up until the completion of the Success Guarantee Plan1

Up to 100% Refund of Cycle Fees

Our Success Guarantee Plans offer peace of mind, cost savings and the opportunity to achieve your goal of a baby or up to 100% of your cycle fees refunded.

Program Criteria

General Criteria

  • Patients who wish to utilize medical insurance coverage for treatment cycles are excluded from applying/participating.
  • Patients who need Preimplantation Genetic Testing for Monogenic/Single Gene Defects (PGT-M) will be disqualified.
  • Participants in program (egg provider, sperm provider, and embryo transfer recipient) who smoke will be disqualified.
  • The lab must be able to use ICSI at their discretion for optimum fertilization.
  • This program only applies to embryos created from one egg retrieval, from one egg provider.
  • Using the same combination of egg provider, sperm provider and embryo transfer recipient, previous IVF cycles must have produced >5 quality blastocyst embryos on Day 5 or 6. If PGT-A was performed, the previous cycles must have produced >3 euploid Blastocyst embryos.
  • Using the same combination of egg provider, sperm provider and embryo transfer recipient, the intended parents must not have failed >2 previous embryo transfers in attempts to conceive.
  • The Patient and Partner, if applicable, in consultation with the physicians and embryologist, will determine the number of embryos/blastocysts placed per each transfer. We adhere to the established transfer guidelines published by the American Society of Reproductive Medicine (ASRM).
  • The couple must agree to have all embryos transferred (regardless of gender), either fresh or thawed, before the cycle is considered complete per the program. The retrieval and all transfers within this program must occur at SDFC. Refunds are not given if tissue is moved outside of our center.

The Egg Provider

  • Anti-Mullerian Hormone (AMH) ≥1.5.
  • Day 3 FSH ≤9.0mIU/ml – must be drawn within 6 months of IVF cycle start.
  • Day 3 Estradiol ≤65pg/ml – must be drawn within 6 months of IVF cycle start.
  • Antral Follicle Count (AFC) ≥12.
  • Infectious disease test results must be normal.

The Sperm Provider

  • Semen Analysis within the preceding 12 months.
  • The man must be capable of producing sperm in his ejaculate or be willing to go through a procedure to obtain sperm or use a sperm donor.
  • If the sperm provider requires a sperm extraction procedure like TESE/TESA/MESA, then donor sperm must be arranged as a back-up option if sperm cannot be obtained through these procedures.
  • If couple is unwilling to use donor sperm as back up, and there is no sperm found on the TESE/TESA/MESA then the Success Guarantee contract will be void, the appropriate package (typically, egg freeze) will be charged, and the difference refunded.
  • Infectious disease test results must be normal.

The Recipient (Uterus)

  • The embryo recipient must be physically and mentally healthy enough to undertake a pregnancy.
  • The embryo recipient must have a normal uterus as assessed by a transvaginal ultrasound and a normal hysterosalpingogram, sonohysterogram and/or hysteroscopy performed in the preceding 12 months. A normal uterus will show no uterine anomalies.
  • In previous fertility treatment therapies, the embryo recipient must have shown a sufficient endometrial response, as demonstrated by a peak endometrial thickness of ≥8mm, with an endometrial pattern that is trilaminar in appearance, during estrogenic stimulation in the proliferative phase of the menstrual cycle. If recipient has no medical evidence of achieving an endometrial lining ≥8mm with a trilaminar appearance within 12 months, a mock cycle will be required.
  • If the embryo recipient has submucosal fibroids, they must be removed, and confirmation of a normal uterine cavity must be documented post-surgery.
  • If the embryo recipient has intramural fibroids, they must be <3cm.
  • The embryo recipient must have no evidence of a hydrosalpinx.
  • Surrogates must have a BMI of <32, all other embryo recipients must have a BMI of <30.
  • The embryo recipient must have no history of uterine surgery (e.g., myomectomy, treatment of Asherman’s Syndrome, nor correction of uterine anomalies).
  • The embryo recipient must have no evidence of Stage III (or greater) endometriosis, nor a suggestion of adenomyosis on imaging.
  • Infectious disease test results must be normal.
  • Surrogates must be 44 years old or less to be accepted under this program, unless there are extenuating circumstances, which are handled on an exception basis. Maternal-Fetal Medicine (MFM) counseling may be required.